Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Immunoprecise Antibodies Ltd
NASDAQ:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
NASDAQ:IPA
Watchlist
Price: 2.07 USD 7.25% Market Closed
Market Cap: $95.5m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
Jan 31, 2022 56.5m
Oct 31, 2021 60.3m
Jul 31, 2021 64.4m
Apr 30, 2021 67m
Liabilities
+
Jan 31, 2022 8.8m
Oct 31, 2021 9.4m
Jul 31, 2021 9m
Apr 30, 2021 10m
Equity
+
Jan 31, 2022 47.7m
Oct 31, 2021 50.9m
Jul 31, 2021 55.4m
Apr 30, 2021 56.9m

Balance Sheet Decomposition
Immunoprecise Antibodies Ltd

Balance Sheet
Immunoprecise Antibodies Ltd

Rotate your device to view
Balance Sheet
Currency: CAD
Apr-2018 Apr-2019 Apr-2020 Apr-2021
Assets
Cash & Cash Equivalents
2
5
3
42
Cash
2
5
3
42
Total Receivables
2
2
4
4
Accounts Receivables
2
2
4
4
Other Receivables
0
0
0
0
Inventory
0
2
1
1
Other Current Assets
0
0
1
2
Total Current Assets
5
10
8
49
PP&E Net
2
2
3
4
PP&E Gross
0
0
3
4
Accumulated Depreciation
0
0
3
4
Intangible Assets
4
8
8
6
Long-Term Investments
0
0
0
0
Other Long-Term Assets
9
0
0
0
Other Assets
5
8
8
8
Total Assets
25
N/A
28
+15%
27
-4%
67
+146%
Liabilities
Accounts Payable
2
0
0
0
Short-Term Debt
0
0
0
0
Current Portion of Long-Term Debt
0
3
3
1
Other Current Liabilities
2
3
3
2
Total Current Liabilities
4
7
8
6
Long-Term Debt
4
0
1
2
Deferred Income Tax
1
2
2
1
Other Liabilities
3
1
1
0
Total Liabilities
12
N/A
10
-13%
12
+18%
10
-18%
Equity
Common Stock
20
33
34
80
Retained Earnings
10
17
22
30
Additional Paid In Capital
2
3
4
7
Other Equity
0
0
0
1
Total Equity
13
N/A
18
+42%
15
-16%
57
+277%
Total Liabilities & Equity
25
N/A
28
+15%
27
-4%
67
+146%
Shares Outstanding
Common Shares Outstanding
11
14
14
19

See Also

Summary
IPA intrinsic value, competitors valuation, and company profile.
DCF Valuation
IPA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IPA stock valuation using valuation multiples.
Wall Street Estimates
IPA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IPA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.